Jack Ma-Backed Biotech Firm Brii Considers Hong Kong IPO

(Bloomberg) -- Brii Biosciences, which focuses on treatments for diseases such as Covid-19 and HIV, is considering an initial public offering in Hong Kong as soon as the first quarter of next year,...